Vicki Reed - Field Trip Chief Officer
FTHWFDelisted Stock | USD 0.04 0.00 0.00% |
Insider
Vicki Reed is Chief Officer of Field Trip Health
Phone | 833-222-0084 |
Web | https://www.fieldtriphealth.com |
Similar Executives
Showing other executives | INSIDER Age | ||
Joseph McGuire | MAIA Biotechnology | 66 | |
Sergei Gryaznov | MAIA Biotechnology | 65 | |
Sujal Patel | Nautilus Biotechnology | 50 | |
Kyung NamWortman | Cellectis SA | 53 | |
Anna Mowry | Nautilus Biotechnology | 41 | |
BBus FCPA | Telix Pharmaceuticals Limited | 57 | |
Gwen Weld | Nautilus Biotechnology | 67 | |
Christina BBA | Antibe Therapeutics | N/A | |
MBA MSc | Antibe Therapeutics | 65 | |
LLB JD | Antibe Therapeutics | 65 | |
Valerie Cros | Cellectis SA | N/A | |
MSc MSc | Cellectis SA | 54 | |
Edward DVM | SAB Biotherapeutics | N/A | |
Ranga MD | India Globalization Capital | 60 | |
Jyoti BappSc | Telix Pharmaceuticals Limited | N/A | |
MBA CMA | SAB Biotherapeutics | 69 | |
Dr MBA | Cellectis SA | 46 | |
Jean Epinat | Cellectis SA | N/A | |
Meredith Crowe | Telix Pharmaceuticals Limited | N/A | |
Mihail MD | MAIA Biotechnology | 65 | |
BSc BSc | Telix Pharmaceuticals Limited | N/A |
Field Trip Health Leadership Team
Elected by the shareholders, the Field Trip's board of directors comprises two types of representatives: Field Trip inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Field. The board's role is to monitor Field Trip's management team and ensure that shareholders' interests are well served. Field Trip's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Field Trip's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ronan Levy, Founder CEO | ||
Chet Lakhani, VP Product | ||
Donna Wong, VP Inc | ||
Vicki Reed, Chief Officer | ||
Mujeeb Jafferi, Founder Pres | ||
Amardeep Manhas, Chief Officer | ||
Stacey Hoisak, Sr Counsel | ||
Edgar Diaz, VP Operations |
Field Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Field Trip a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 19.22 M | |||
Shares Outstanding | 89.88 M | |||
Shares Owned By Insiders | 22.99 % | |||
Shares Owned By Institutions | 22.41 % | |||
Market Capitalization | 6.96 M |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Field Pink Sheet
If you are still planning to invest in Field Trip Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Field Trip's history and understand the potential risks before investing.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |